83 related articles for article (PubMed ID: 25335814)
1. Fractal analysis of circulating platelets in type 2 diabetic patients.
Bianciardi G; Tanganelli I
Clin Hemorheol Microcirc; 2015; 61(1):91-7. PubMed ID: 25335814
[TBL] [Abstract][Full Text] [Related]
2. Geometric complexity is increased in in vitro activated platelets.
Bianciardi G
Microsc Res Tech; 2015 Jun; 78(6):485-8. PubMed ID: 25808036
[TBL] [Abstract][Full Text] [Related]
3. Geometric complexity identifies platelet activation in familial hypercholesterolemic patients.
Bianciardi G; Aglianò M; Volpi N; Stefanutti C
Microsc Res Tech; 2015 Jun; 78(6):519-22. PubMed ID: 25877374
[TBL] [Abstract][Full Text] [Related]
4. Platelet entropy is increased in familial hypercholesterolemia and in type 2 diabetic patients.
Bianciardi G; Stefanutti C; Tanganelli I
Int Angiol; 2015 Oct; 34(5):489-94. PubMed ID: 25669620
[TBL] [Abstract][Full Text] [Related]
5. Fractal analysis of monocytes in diabetes.
Bianciardi G; Tanganelli I; Totagiancaspro D; Brogi M; Carducci A; De Santi MM
Clin Hemorheol Microcirc; 2006; 35(1-2):269-72. PubMed ID: 16899941
[TBL] [Abstract][Full Text] [Related]
6. Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.
Tarnow I; Michelson AD; Barnard MR; Frelinger AL; Aasted B; Jensen BR; Parving HH; Rossing P; Tarnow L
Platelets; 2009 Nov; 20(7):513-9. PubMed ID: 19852691
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of platelets type 2 diabetes mellitus reveals 'angry' platelets.
Soma P; Swanepoel AC; du Plooy JN; Mqoco T; Pretorius E
Cardiovasc Diabetol; 2016 Mar; 15():52. PubMed ID: 27036108
[TBL] [Abstract][Full Text] [Related]
8. Normal platelet function, but increased platelet activation in vivo in diabetic patients.
Tomaselli L; Cerletti C; de Gaetano G; Notarbartolo A; Davì G; Pupillo M
Thromb Haemost; 1990 Dec; 64(4):604. PubMed ID: 2128141
[No Abstract] [Full Text] [Related]
9. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.
Mutus B; Rabini RA; Staffolani R; Ricciotti R; Fumelli P; Moretti N; Martarelli D; Mazzanti L
Diabetologia; 2001 Aug; 44(8):979-82. PubMed ID: 11484074
[TBL] [Abstract][Full Text] [Related]
10. Fractal and Euclidean descriptors of platelet shape.
Kraus MJ; Neeb H; Strasser EF
Platelets; 2014; 25(7):488-98. PubMed ID: 24224894
[TBL] [Abstract][Full Text] [Related]
11. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
[TBL] [Abstract][Full Text] [Related]
12. Unusual shape and structure of lymphocyte nuclei is linked to hyperglycemia in type 2 diabetes patients.
Martinovic T; Ciric D; Pantic I; Lalic K; Rasulic I; Despotovic S; Lalic I; Djuricic D; Bumbasirevic V; Kravic-Stevovic T
Tissue Cell; 2018 Jun; 52():92-100. PubMed ID: 29857834
[TBL] [Abstract][Full Text] [Related]
13. Platelet-leukocyte-cross-talk in diabetes mellitus.
Tschoepe D; Rauch U; Schwippert B
Horm Metab Res; 1997 Dec; 29(12):631-5. PubMed ID: 9497901
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets.
Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS
Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794
[TBL] [Abstract][Full Text] [Related]
15. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
16. Platelet protein kinase C isoform content in type 2 diabetes complicated with retinopathy and nephropathy.
Kimura M; Ishizawa M; Miura A; Itaya S; Kanoh Y; Yasuda K; Uno Y; Morita H; Ishizuka T
Platelets; 2001 May; 12(3):138-43. PubMed ID: 11304414
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the transfer of phospholipids from very-low density lipoproteins to activated platelets in type 2 diabetes.
Ibrahim S; Guillot N; Pruneta-Deloche V; Charrière S; Calzada C; Guichardant M; Moulin P; Lagarde M; Ponsin G
Atherosclerosis; 2009 Mar; 203(1):119-25. PubMed ID: 18619595
[TBL] [Abstract][Full Text] [Related]
18. Effect of Clopidogrel on Platelet CD Markers in Normal Individuals and in Patients with Untreated Type 2 Diabetes Mellitus.
Saboor M; Moinuddin ; Ilyas S
J Coll Physicians Surg Pak; 2015 May; 25(5):380-2. PubMed ID: 26008670
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation patterns are different in mouse models of diabetes and chronic inhibition of nitric oxide synthesis.
Rozalski M; Kassassir H; Siewiera K; Klepacka A; Sychowski R; Watala C
Thromb Res; 2014 Jun; 133(6):1097-104. PubMed ID: 24731558
[TBL] [Abstract][Full Text] [Related]
20. Circulating platelet activation in healthy subjects and in some pathological conditions. Method of study and results.
Bologna E; Traietti P
Boll Soc Ital Biol Sper; 1990 Apr; 66(4):343-7. PubMed ID: 2390224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
